Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in J Clin Psychopharmacol

Retrieve available abstracts of 67 articles:
HTML format

Single Articles

    November 2021
  1. MAURI MC, Franco G, Minutillo A, Paletta S, et al
    The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly: Clinical Pharmacokinetic Evaluation in Patients With Schizophrenia (Preliminary Data).
    J Clin Psychopharmacol. 2021 Nov 24. pii: 00004714-900000000-98229.
    PubMed     Abstract available

  2. RUDA D, Jensen KG, Decara MS, Klauber DG, et al
    CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis.
    J Clin Psychopharmacol. 2021;41:667-672.
    PubMed     Abstract available

  3. WEIZMAN S, Shelef A, Bloemhof Bris E, Stryjer R, et al
    A Double-Blind, Placebo-Controlled Trial of Bupropion Add-on to Olanzapine or Risperidone in Overweight Individuals With Schizophrenia.
    J Clin Psychopharmacol. 2021;41:629-631.
    PubMed     Abstract available

  4. COMAI S, Fuamba Y, Rivolta MC, Gobbi G, et al
    Lifetime Cannabis Use Disorder Is Not Associated With Lifetime Impulsive Behavior and Severe Violence in Patients With Schizophrenia Spectrum Disorders From a High-Security Hospital.
    J Clin Psychopharmacol. 2021;41:623-628.
    PubMed     Abstract available

  5. MAKHLOUF AT, Van Alphen MU, Manzano GS, Freudenreich O, et al
    A Seizure After COVID-19 Vaccination in a Patient on Clozapine.
    J Clin Psychopharmacol. 2021;41:689-690.

    September 2021
  6. SRIFUENGFUNG M, Sukakul T, Pummangura C, Srifuengfung S, et al
    Oral Ulcers as an Unpredictable Adverse Reaction to Quetiapine Use in a Patient With Schizophrenia.
    J Clin Psychopharmacol. 2021 Sep 9. pii: 00004714-900000000-98247.

    August 2021
  7. PEITL V, Badzim VA, Sisko Markos I, Rendulic A, et al
    Improvements of Frontotemporal Cerebral Blood Flow and Cognitive Functioning in Patients With First Episode of Schizophrenia Treated With Long-Acting Aripiprazole.
    J Clin Psychopharmacol. 2021 Aug 26. pii: 00004714-900000000-98248.
    PubMed     Abstract available

  8. OGAWA T, Tachikawa H, Shiratori Y, Sodeyama N, et al
    Use of Blonanserin Transdermal Patch in Home Treatment of Schizophrenia: A Case Study.
    J Clin Psychopharmacol. 2021 Aug 23. pii: 00004714-900000000-98251.

  9. LIM M, Li Z, Xie H, Tan BL, et al
    The Effect of Therapeutic Alliance on Attitudes Toward Psychiatric Medications in Schizophrenia.
    J Clin Psychopharmacol. 2021 Aug 13. pii: 00004714-900000000-98260.
    PubMed     Abstract available

    July 2021

  10. Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia: Erratum.
    J Clin Psychopharmacol. 2021;41:507.

    June 2021
  11. KOREKI A, Mori H, Nozaki S, Koizumi T, et al
    Risk of Nonalcoholic Fatty Liver Disease in Patients With Schizophrenia Treated With Antipsychotic Drugs: A Cross-sectional Study.
    J Clin Psychopharmacol. 2021 Jun 4. pii: 00004714-900000000-98299.
    PubMed     Abstract available

    May 2021
  12. SUHAS S, Shivani S, Singh GK, Venkatasubramanian G, et al
    Festina Lente: Betahistine for Clozapine-Associated Weight Gain: A Case Report.
    J Clin Psychopharmacol. 2021;41:332-333.

  13. SUZUKI K, Castelli M, Komaroff M, Starling B, et al
    Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070).
    J Clin Psychopharmacol. 2021;41:286-294.
    PubMed     Abstract available

  14. MATHUR R, Singh J, Sood M
    A Case Report of Clozapine-Associated Stuttering and Amisulpride-Associated Stuttering and Seizure in an Adult on Concurrent Fluoxetine Therapy.
    J Clin Psychopharmacol. 2021;41:330-332.

  15. TIRUPATI S, Gordon T
    Continuation of Treatment With Clozapine After an Episode of Neutropenia.
    J Clin Psychopharmacol. 2021;41:320-322.
    PubMed     Abstract available

    April 2021
  16. GUIMARAES TM, Guimaraes MRC, Oliveira IAF, Leoni RF, et al
    Mononitrate Isosorbide as an Adjunctive Therapy in Schizophrenia: A Randomized Controlled Crossover Trial.
    J Clin Psychopharmacol. 2021 Apr 14. pii: 00004714-900000000-98311.
    PubMed     Abstract available

    Augmentation With Pimavanserin in Treatment Refractory Schizophrenia: Case Report.
    J Clin Psychopharmacol. 2021 Apr 13. pii: 00004714-900000000-98312.

    March 2021
  18. AN H, Fan H, Chen S, Qi S, et al
    Effects of Dose, Age, Sex, Body Weight, and Smoking on Plasma Concentrations of Olanzapine and N-desmethyl Olanzapine in Inpatients With Schizophrenia.
    J Clin Psychopharmacol. 2021 Mar 31. pii: 00004714-900000000-98320.
    PubMed     Abstract available

  19. WANG J, Hart KL, Qi W, Ardekani BA, et al
    Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia.
    J Clin Psychopharmacol. 2021 Mar 31. pii: 00004714-900000000-98319.
    PubMed     Abstract available

  20. BUCHANAN RW, Kelly DL, Strauss GP, Gold JM, et al
    Combined Oxytocin and Cognitive Behavioral Social Skills Training for Social Function in People With Schizophrenia.
    J Clin Psychopharmacol. 2021 Mar 30. pii: 00004714-900000000-98321.
    PubMed     Abstract available

  21. BALDAQUI N, Anmella G, Gomez-Ramiro M, Guasp M, et al
    Thyrotoxic Psychosis Associated With Amiodarone.
    J Clin Psychopharmacol. 2021 Mar 12. pii: 00004714-900000000-98331.

  22. LECLERC LD, Demers MF, Bardell A, Bilodeau I, et al
    A Chart Audit Study of Clozapine Utilization in Early Psychosis.
    J Clin Psychopharmacol. 2021 Mar 12. pii: 00004714-900000000-98327.
    PubMed     Abstract available

  23. IWATA Y, Aruga Y, Ohtsuki M, Inoue M, et al
    Successful Introduction of Paliperidone Palmitate for Pregnant Woman With Schizophrenia: Case Presentation and Literature Review.
    J Clin Psychopharmacol. 2021;41:210-212.

  24. REHIMINI S, Goddard KG, Margolese HC
    Exceptionally High Clozapine-Associated Eosinophilia.
    J Clin Psychopharmacol. 2021;41:216-218.

  25. GROVER S, Naskar C, Chakrabarti S
    Does the Starting of Clozapine Influence Coprescription of Other Medications?: A Study From India.
    J Clin Psychopharmacol. 2021;41:148-154.
    PubMed     Abstract available

  26. GRIFFIN JM, Woznica E, Gilotra NA, Nucifora FC Jr, et al
    Clozapine-Associated Myocarditis: A Protocol for Monitoring Upon Clozapine Initiation and Recommendations for How to Conduct a Clozapine Rechallenge.
    J Clin Psychopharmacol. 2021;41:180-185.
    PubMed     Abstract available

  27. YILDIZ MI, Karacam Dogan M, Mutlu E, Abdullayeva L, et al
    All in One: Clozapine-Associated Acute Pancreatitis With Multiple Organ Involvement.
    J Clin Psychopharmacol. 2021;41:214-216.

  28. KHURRAM SK, Ames M, Muniz J
    Case Report: Valbenazine as a Treatment for Tardive Dyskinesia and Unexpected Antipsychotic Effects.
    J Clin Psychopharmacol. 2021;41:220-221.

  29. MISAWA F, Fujii Y, Takeuchi H
    Can a 4-Month Tolerability Assessment With Paliperidone Palmitate 1-Monthly Prevent Neuroleptic Malignant Syndrome Associated With the 3-Monthly?: Analysis Based on a Spontaneous Reporting System Database in Japan.
    J Clin Psychopharmacol. 2021;41:206-207.

  30. DANILEWITZ M, Rafizadeh R, Bousman CA
    Successful Clozapine Rechallenge After Suspected Clozapine-Associated Myocarditis: A Case Report.
    J Clin Psychopharmacol. 2021;41:218-220.

    February 2021
  31. BENGTSSON J, Olsson E, Igelstrom H, Persson J, et al
    Ambulatory Heart Rate Variability in Schizophrenia or Depression: Impact of Anticholinergic Burden and Other Factors.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98342.
    PubMed     Abstract available

  32. ANDARI E, Massa NM, Fargotstein MD, Taylor NB, et al
    Effects of Oxytocin on Emotion Recognition in Schizophrenia: A Randomized Double-Blind Pilot Study.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98352.
    PubMed     Abstract available

    Long-Term Improvement of Aggression in a Patient With Schizophrenia Using Allopurinol as an Adjuvant: A Case Report.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98348.

    Binge Eating Disorders in Antipsychotic-Treated Patients With Schizophrenia: Prevalence, Antipsychotic Specificities, and Changes Over Time.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98347.
    PubMed     Abstract available

  35. LEISING J, Barr AM, Procyshyn RM, Ainsworth NJ, et al
    High-Dose Fluvoxamine Augmentation to Clozapine in Treatment-Resistant Psychosis.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98344.
    PubMed     Abstract available

  36. KELLY DL, Kane MA, Fraser CM, Sayer MA, et al
    Prebiotic Treatment Increases Serum Butyrate in People With Schizophrenia: Results of an Open-Label Inpatient Pilot Clinical Trial.
    J Clin Psychopharmacol. 2021 Feb 11. pii: 00004714-900000000-98356.

  37. BO Q, Xing X, Li T, Mao Z, et al
    Menstrual Dysfunction in Women With Schizophrenia During Risperidone Maintenance Treatment.
    J Clin Psychopharmacol. 2021 Feb 1. pii: 00004714-900000000-98361.
    PubMed     Abstract available

    January 2021
  38. PRIDMORE S, Naguy A, Moodliar-Rensburg S, Alamiri B, et al
    Advantageous Add-on Duloxetine to Aripiprazole-Responsive Early-Onset Schizophrenia.
    J Clin Psychopharmacol. 2021;41:91-92.

  39. SUBEESH V, Maheswari E, Singh H, Neha R, et al
    Finding Early Improvement Threshold to Predict Response After 8 Weeks of Treatment Using Risperidone in First-Episode Psychosis.
    J Clin Psychopharmacol. 2021;41:58-61.
    PubMed     Abstract available

  40. MAGUIRE A, Mooney C, Flynn G, Ferguson Y, et al
    No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial.
    J Clin Psychopharmacol. 2021;41:53-57.
    PubMed     Abstract available

  41. VERMA M, Grover S, Chakrabarti S
    Cost of the Illness of Treatment-Resistant Schizophrenia: A Mirror Image Study Comparing Clozapine With Other Antipsychotics.
    J Clin Psychopharmacol. 2021;41:36-44.
    PubMed     Abstract available

  42. HOSSEININASAB M, Zarghami M, Mazhari S, Salehifar E, et al
    Nanocurcumin as an Add-on to Antipsychotic Drugs for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study.
    J Clin Psychopharmacol. 2021;41:25-30.
    PubMed     Abstract available

  43. BLACKMAN G, Lisshammar JEL, Zafar R, Pollak TA, et al
    Clozapine Response in Schizophrenia and Hematological Changes.
    J Clin Psychopharmacol. 2021;41:19-24.
    PubMed     Abstract available

    November 2020
  44. LE MOIGNE A, Fava M, Csernansky J, Newcomer JW, et al
    Reanalysis of a Phase 3 Trial of a Monthly Extended-Release Risperidone Injection for the Treatment of Acute Schizophrenia.
    J Clin Psychopharmacol. 2020 Nov 16. doi: 10.1097/JCP.0000000000001319.

    Psychosis Treatment During COVID-19 Pandemic and the Potential Role of Phenothiazines: A Call for Research Studies.
    J Clin Psychopharmacol. 2020;40:641-642.

  46. DROSOS P, Bronnick K, Joa I, Johannessen JO, et al
    One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia: Results From a Consecutive Cohort Study.
    J Clin Psychopharmacol. 2020;40:534-540.
    PubMed     Abstract available

    October 2020
  47. NGUYEN AS, Grossman-Kahn R, Wichser L
    Anticipatory Clozapine Dosing After Discharge From Inpatient Treatment for the Patient With Comorbid Schizophrenia and Tobacco Use.
    J Clin Psychopharmacol. 2020 Oct 14. doi: 10.1097/JCP.0000000000001294.

    September 2020
  48. MEYER RE
    Thoughts About Schizophrenia 66 Years After Chlorpromazine.
    J Clin Psychopharmacol. 2020;40:436-438.

  49. CHEN B, Wang C, Xu X, Lyu H, et al
    Risk of Prolonged Corrected QT Interval With Amisulpride Therapy for Renal Function Management in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2020;40:482-486.
    PubMed     Abstract available

    August 2020
  50. VAHDANI B, Armani Kian A, Esmaeilzadeh A, Zenoozian S, et al
    Adjunctive Raloxifene and Isradipine Improve Cognitive Functioning in Patients With Schizophrenia: A Pilot Study.
    J Clin Psychopharmacol. 2020 Aug 11. doi: 10.1097/JCP.0000000000001274.
    PubMed     Abstract available

  51. BUCHANAN RW, Weiner E, Kelly DL, Gold JM, et al
    Anti-inflammatory Combination Therapy for the Treatment of Schizophrenia.
    J Clin Psychopharmacol. 2020 Aug 11. doi: 10.1097/JCP.0000000000001253.
    PubMed     Abstract available

    July 2020
  52. OHI K, Muto Y, Sugiyama S, Shioiri T, et al
    Safety and Efficacy in Randomized Controlled Trials of Second-Generation Antipsychotics Versus Placebo for Cognitive Impairments in Schizophrenia: A Meta-Analysis.
    J Clin Psychopharmacol. 2020 Jul 24. doi: 10.1097/JCP.0000000000001232.

  53. KWON JS, Lee J, Kim E, Kim SW, et al
    A Prospective Study for Prediction of Psychotic Relapse Using the Korean Early Signs Scale in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2020 Jul 21. doi: 10.1097/JCP.0000000000001263.
    PubMed     Abstract available

  54. MOGHIMI SARANI E, Memari E, Anushiravani A, Mowla A, et al
    Is Sitagliptin Effective for Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients? A Double-blind Placebo-controlled Clinical Trial.
    J Clin Psychopharmacol. 2020 Jul 21. doi: 10.1097/JCP.0000000000001259.
    PubMed     Abstract available

  55. DONDE C, Polosan M, Guzun R
    Pitolisant for Treating Narcolepsy Comorbid With Schizophrenia.
    J Clin Psychopharmacol. 2020 Jul 15. doi: 10.1097/JCP.0000000000001243.

  56. BRUNO A, Zoccali RA, Troili GM, Scala L, et al
    Vortioxetine on Cognition in Schizophrenia: A Pilot Study.
    J Clin Psychopharmacol. 2020;40:381-385.
    PubMed     Abstract available

  57. ROJNIC KUZMAN M, Makaric P, Bosnjak Kuharic D, Kekin I, et al
    General Functioning in Patients With First-Episode Psychosis After the First 18 Months of Treatment.
    J Clin Psychopharmacol. 2020;40:366-372.
    PubMed     Abstract available

  58. LINDENMAYER JP, Glick ID, Talreja H, Underriner M, et al
    Persistent Barriers to the Use of Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia.
    J Clin Psychopharmacol. 2020;40:346-349.
    PubMed     Abstract available

  59. ZHENG W, Xiang YQ, Cai DB, Yang XH, et al
    Adjunctive Fluvoxamine for Schizophrenia: A Meta-analysis of Randomized Double-Blind, Placebo-Controlled Trials.
    J Clin Psychopharmacol. 2020;40:386-390.
    PubMed     Abstract available

  60. CAROFF SN, Leong SH, Roberts CB, Berkowitz RM, et al
    Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive Dyskinesia.
    J Clin Psychopharmacol. 2020;40:373-380.
    PubMed     Abstract available

    May 2020
  61. YESILKAYA UH, Balcioglu YH
    Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia: Anti-obsessional Efficacy of Partial Agonism.
    J Clin Psychopharmacol. 2020 May 19. doi: 10.1097/JCP.0000000000001214.

  62. BIRNBAUM R, Weinberger DR
    Special Article: Translational Science Update. Pharmacological Implications of Emerging Schizophrenia Genetics: Can the Bridge From 'Genomics' to 'Therapeutics' be Defined and Traversed?
    J Clin Psychopharmacol. 2020 May 18. doi: 10.1097/JCP.0000000000001215.
    PubMed     Abstract available

  63. FRIENDSHUH CR, Pocivavsek A, Demyonovich H, Rodriguez KM, et al
    The Effects of a Gluten-Free Diet on Immune Markers and Kynurenic Acid Pathway Metabolites in Patients With Schizophrenia Positive for Antigliadin Antibodies Immunoglobulin G.
    J Clin Psychopharmacol. 2020;40:317-319.

  64. KUZIN M, Bochon B, Vagiaris E, Dammann G, et al
    Changes in Clozapine Bioavailability in a Percutaneous Endoscopic Gastrostomy-Fed Patient With Treatment-Resistant Schizophrenia.
    J Clin Psychopharmacol. 2020;40:306-308.

  65. MELTZER HY, Share DB, Jayathilake K, Salomon RM, et al
    Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia.
    J Clin Psychopharmacol. 2020;40:240-249.
    PubMed     Abstract available

    January 2020
  66. SUGAI T, Suzuki Y, Yamazaki M, Sugawara N, et al
    Lower Prolactin Levels in Patients Treated With Aripiprazole Regardless of Antipsychotic Monopharmacy or Polypharmacy.
    J Clin Psychopharmacol. 2020;40:14-17.
    PubMed     Abstract available

  67. SMITH C, Gwynn N, Lindenmayer JP
    Pisa Syndrome and Aripiprazole.
    J Clin Psychopharmacol. 2020;40:99-101.

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.